Dongcheng Pharmaceutical (002675.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 647 million yuan, a year-on-year decrease of 23.90%. Net profit attributable to shareholders of listed companies was 64.327 million yuan, an increase of 28.38% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $54.85 million, an increase of 29.40% over the previous year.
东诚药业(002675.SZ)发布一季度业绩，净利润6432.75万元，增长28.38%
Dongcheng Pharmaceutical (002675.SZ) announced first-quarter results, net profit of 64.327 million yuan, an increase of 28.38%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.